{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:22:30Z","timestamp":1778786550616,"version":"3.51.4"},"reference-count":40,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014730","name":"Taipei City Government","doi-asserted-by":"publisher","award":["TCHIRB\u201010402102"],"award-info":[{"award-number":["TCHIRB\u201010402102"]}],"id":[{"id":"10.13039\/501100014730","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Neuropsychopharm Rep"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>Quetiapine is widely used to treat psychiatric disorders such as major depression, generalized anxiety disorder, dysthymic disorder, and insomnia other than schizophrenia and bipolar disorder. This study investigated the diagnostic distribution of quetiapine use in patients in a psychiatric hospital, the doses of quetiapine prescribed, and the plasma concentrations (Cps) of quetiapine and active metabolites.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We enrolled 107 patients who had been prescribed quetiapine for at least 4\u2009weeks. Diagnoses, demographics, and concomitant medications were recorded. Blood sampling was performed in the morning, approximately 12\u00a0h after the before\u2010bed dose of quetiapine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Diagnoses comprised schizophrenia (<jats:italic>n<\/jats:italic>\u00a0=\u00a025), bipolar disorder (<jats:italic>n<\/jats:italic>\u00a0=\u00a051), major depression (<jats:italic>n<\/jats:italic>\u00a0=\u00a015), dysthymic disorder (<jats:italic>n<\/jats:italic>\u00a0=\u00a09), and others (<jats:italic>n<\/jats:italic>\u00a0=\u00a07). The daily dose (DD) of quetiapine ranged from 25 to 800 (175.9\u2009\u00b1\u2009184.4)\u00a0mg, with the mean Cp being 105.6\u2009\u00b1\u2009215.3\u00a0ng\/ml, with a mean Cps\/DD ratio of 0.58\u2009\u00b1\u20090.55\u2009ng\/ml\/mg. There was a moderate positive linear correlation between the dose and Cps of quetiapine (<jats:italic>r<\/jats:italic>\u00a0=\u00a00.60), and the interpatient variation in Cps\/DD ratio was up to 26\u2010fold.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Quetiapine is used in various doses to treat many psychiatric disorders other than psychosis, and it is usually prescribed as a secondary antipsychotic for symptoms such as insomnia or agitation. A wide interpatient variation of the Cps\/DD ratio was noticed. Patients of East Asian descent may exhibit a 50% to 100% increase in the Cps\/DD ratio for quetiapine compared with patients of Western descent.<\/jats:p><\/jats:sec>","DOI":"10.1002\/npr2.12303","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T04:28:34Z","timestamp":1673929714000},"page":"50-56","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Post\u2010therapy plasma concentrations of quetiapine in Taiwanese patients"],"prefix":"10.1002","volume":"43","author":[{"given":"Cho\u2010Yin","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Psychiatry Taipei City Hospital and Psychiatric Center  Taipei Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen\u2010Feng","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Taipei City Hospital and Psychiatric Center  Taipei Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia\u2010Ru","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Taipei City Hospital and Psychiatric Center  Taipei Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5123-0389","authenticated-orcid":false,"given":"Shih\u2010Ku","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry Taipei City Hospital and Psychiatric Center  Taipei Taiwan"},{"name":"Department of Psychiatry Linkou Chang Gung Memorial Hospital  Taoyuan Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1092852900020307"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2010.06.031"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1461145709990423"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32833e34d9"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp130221"},{"issue":"13","key":"e_1_2_11_7_1","first-page":"5","article-title":"Quetiapine: preclinical studies, pharmacokinetics, drug interactions, and dosing","volume":"63","author":"Nemeroff CB","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77106-x"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200140070-00003"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1600991"},{"key":"e_1_2_11_11_1","first-page":"599","article-title":"Clozapine dosages and plasma drug concentrations","volume":"96","author":"Chang WH","year":"1997","journal-title":"J Formos Med Assoc"},{"key":"e_1_2_11_12_1","first-page":"671","article-title":"Haloperidol plasma concentrations in Taiwanese psychiatric patients","volume":"94","author":"Lane HY","year":"1995","journal-title":"J Formos Med Assoc"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199631030-00004"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e3283430a0e"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.4320"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v68n1011"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2005.02507.x"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03941.x"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0306-5251.2001.01474.x"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000188213.46667.f1"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-007-0968-8"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.27286"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301646"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31821160c4"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200410000-00005"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e3182603f62"},{"key":"e_1_2_11_27_1","first-page":"268","article-title":"Novel mutations of CYP3A4 in Chinese","volume":"29","author":"Hsieh KP","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250400021796"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10038-006-0034-0"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(84)90017-9"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/0278-5846(92)90070-U"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045125312470677"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31828d221f"},{"key":"e_1_2_11_34_1","first-page":"390","article-title":"Multiple dose pharmacokinetics of quetiapine and some of its metabolites in Chinese suffering from schizophrenia","volume":"25","author":"Li KY","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-013-0127-9"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.4103\/IJPSYM.IJPSYM_379_19"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e3182356255"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13466"},{"key":"e_1_2_11_39_1","first-page":"414","article-title":"Interindividual variations in human liver cytochrome P\u2010450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians","volume":"270","author":"Shimada T","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2012.657626"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2008.09.026"}],"container-title":["Neuropsychopharmacology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/npr2.12303","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/npr2.12303","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/npr2.12303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T22:32:21Z","timestamp":1692570741000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/npr2.12303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1002\/npr2.12303"],"URL":"https:\/\/doi.org\/10.1002\/npr2.12303","archive":["Portico"],"relation":{},"ISSN":["2574-173X","2574-173X"],"issn-type":[{"value":"2574-173X","type":"print"},{"value":"2574-173X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"assertion":[{"value":"2022-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-23","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}